The store will not work correctly when cookies are disabled.
4-Ethoxy-4-(4-methoxyphenyl)-4H-[1,2,4]oxadiazolo[3,4-c][1,4]-benzothiazin-1-one
ID: ALA3818560
PubChem CID: 127052463
Max Phase: Preclinical
Molecular Formula: C18H16N2O4S
Molecular Weight: 356.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC1(c2ccc(OC)cc2)Sc2ccccc2-n2c1noc2=O
Standard InChI: InChI=1S/C18H16N2O4S/c1-3-23-18(12-8-10-13(22-2)11-9-12)16-19-24-17(21)20(16)14-6-4-5-7-15(14)25-18/h4-11H,3H2,1-2H3
Standard InChI Key: NFLRTHKJRLAVGF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
1.9460 -1.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6426 -2.0562 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.9460 0.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6426 0.8996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9547 2.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4601 2.5335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0843 1.1566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1496 3.2582 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8879 -2.8393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2237 -0.6086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1565 -3.6397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0977 -5.1385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7703 -5.8370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5016 -5.0366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5605 -3.5378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6609 0.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6609 -1.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9460 -2.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2678 -1.3585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2678 0.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9460 0.8996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7083 -7.3366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6456 -7.8938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5460 -1.3186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5666 -0.6874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17 2 1 0
16 4 1 0
3 1 1 0
1 2 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 3 2 0
5 8 2 0
1 9 1 0
1 10 1 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
13 22 1 0
22 23 1 0
10 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.40 | Molecular Weight (Monoisotopic): 356.0831 | AlogP: 3.18 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.49 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.45 | CX LogD: 4.45 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -0.67 |
References
1. Carosati E, Cosimelli B, Ioan P, Severi E, Katneni K, Chiu FC, Saponara S, Fusi F, Frosini M, Matucci R, Micucci M, Chiarini A, Spinelli D, Budriesi R.. (2016) Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism., 59 (7): [PMID:26962886] [10.1021/acs.jmedchem.6b00030] |